Bruker, an international life science research and diagnostics solutions provider, agreed to acquire ELITech, a global manufacturer of in-vitro diagnostics, from PAI Partners, a private equity firm, for $774m. “ELITechGroup is the company that it is today thanks to our teams' hard work and drive for innovation, and our partnership with PAI. Establishing this unique business within Bruker - a well-respected global life-science tools and specialty diagnostics company - provides an exciting opportunity to further grow our molecular diagnostics, microbiology and biomedical systems portfolios. We expect to capitalize on infectious disease portfolio and commercial synergies for opportunities to further expand our portfolio, utilizing R&D innovations and global customer support within Bruker,” Christoph Gauer, ELITechGroup CEO.